Exonate to launch phase 2b trial of EXN407 for diabetic eye disease - PharmaTimes CLEAR-DE study to assess topical therapy for non-proliferative diabetic retinopathy

#drugdevelopment #Exonate #phase2btrial #EXN407 #diabeticeyedisease #CLEARDEstudy #topicaltherapy #nonproliferativediabeticretinopathy #NPDR #NPDRpatients #diabeticretinopathyprogression #Diabeticretinopathy #diabeticpopulation #VEGFexpression #mRNAsplicing
pharmatimes.com/news/exonate...